IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,030,000 | +5.7% | 52,942 | -9.5% | 0.01% | +25.0% |
Q4 2017 | $974,000 | -26.0% | 58,501 | -9.8% | 0.00% | -42.9% |
Q3 2017 | $1,317,000 | +18.6% | 64,870 | -5.9% | 0.01% | +40.0% |
Q2 2017 | $1,110,000 | +27.3% | 68,970 | 0.0% | 0.01% | +25.0% |
Q1 2017 | $872,000 | +12.4% | 68,970 | +17.8% | 0.00% | 0.0% |
Q4 2016 | $776,000 | -44.1% | 58,532 | 0.0% | 0.00% | -42.9% |
Q3 2016 | $1,387,000 | -11.7% | 58,532 | +7.4% | 0.01% | -12.5% |
Q2 2016 | $1,571,000 | -10.0% | 54,512 | 0.0% | 0.01% | -20.0% |
Q1 2016 | $1,745,000 | -21.0% | 54,512 | +5.5% | 0.01% | -23.1% |
Q4 2015 | $2,209,000 | -7.5% | 51,670 | -0.6% | 0.01% | 0.0% |
Q2 2015 | $2,388,000 | -2.0% | 52,000 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $2,437,000 | +50.0% | 52,000 | +1.4% | 0.01% | +44.4% |
Q4 2014 | $1,625,000 | +22.6% | 51,300 | -8.2% | 0.01% | +12.5% |
Q3 2014 | $1,325,000 | -68.4% | 55,900 | -60.1% | 0.01% | -66.7% |
Q2 2014 | $4,198,000 | +69.0% | 140,000 | +48.9% | 0.02% | +71.4% |
Q1 2014 | $2,484,000 | +47.9% | 94,000 | +40.7% | 0.01% | +40.0% |
Q4 2013 | $1,679,000 | +18.9% | 66,800 | -3.2% | 0.01% | +11.1% |
Q3 2013 | $1,412,000 | – | 69,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |